مشروع البحث:
Effects of COVID-19 on glycemic control in type 2 diabetes patients at the Medical preventive Hospital, Imitiga, Tripoli

تحميل...
thumbnail.project.alt
المساهمين
الممولين
رقم التعريف
2337
الباحث
فاطمة غيت محمد علي
المشرفين
منشورات
وحدات تنظيمية
الوصف
1.1.4.1 SARS-CoV-2 Variants of Concern (VOCs) Alpha (B.1.1.7 lineage): B.1.1.7 lineage, commonly known as Alpha variant or GRY(formerly GR/501Y.V1), a novel SARS-CoV-2 variation of concern was discovered in the UK in late December 2020, based on whole-genome sequencing of samples from patients who tested positive for SARS-CoV-2 (31). It was found in a commonly used commercial test defined by the lack of the S gene (S-gene target failure, SGTF) PCR samples, in addition to being detected by genome sequencing. The viral genome of the B.1.1.7 variant has 17 mutations. The spike (S) protein has about eight mutations. The spike protein has a higher affinity for ACE 2 receptors, which improves viral attachment and subsequent penetration into host cells (55)(56).
الكلمات الدالة
Effects of COVID-19 on glycemic control in type 2 diabetes patients at the Medical preventive Hospital, Imitiga, Tripoli